Laboratoires CYCLOPHARMA are actively developing Public/Private partnerships.
Our dual aim is to:

- Reinforce the valorization of research,
- Supply pharmaceutical laboratories with products enabling them to make progress in diagnosis and therapy for many diseases.

Laboratoires CYCLOPHARMA are seeking to boost the progress of national and European research programs through this partnership method based on local research teams. This goal involves teamwork over our entire national network, with special support provided for new activities and start-ups in this sector.
To ensure the relevance of our commitments, all research projects are submitted to an international scientific committee.

-- Partners

CYCLOPHARMA contributes to the following activity centres:

- Groupement des Industries du Médicament de la Région Auvergne (GIMRA):
  http://www.gimra.info/accueil.html

- Société Française de Médecine Nucléaire (SFMN):
  http://www.sfmn.org/index_org.htm

- Society of Nuclear Medicine (SNM): http://www.snm.org

- European Association of Nuclear Medicine (EANM):
  https://www.eanm.org

- Association of Imaging Producers and Equipment Suppliers (AIPES):
  http://www.aipes-eeig.org

Laboratoires Cyclopharma are involved in developing radiopharmaceuticals for diagnosis and therapy through the GIS Radiopharmaceutique which is based in Saint-Beauzire (63) with : Université François Rabelais, Université Paul Sabatier, CNRS / CI-NAPS, CHU de Lille and Université d’Auvergne .